Arch Venture Fund Viii, L.p. - Net Worth and Insider Trading

Over the past 18 months, Arch Venture Fund Viii, L.p. made no insider transaction in Codiak BioSciences Inc (CDAKQ). Other recent insider transactions involving Codiak BioSciences Inc (CDAKQ) include a net sale of 61,535 shares made by Douglas E Williams , a net sale of 20,226 shares made by Linda Bain , and a net sale of 17,534 shares made by Sriram Sathyanarayanan .

In summary, during the past 3 months, insiders sold 0 shares of Codiak BioSciences Inc (CDAKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 129,081 shares of Codiak BioSciences Inc (CDAKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 129,081 shares.

Codiak BioSciences Inc (CDAKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Fund Viii, L.p. made no insider transaction in Metacrine Inc (MTCR). Other recent insider transactions involving Metacrine Inc (MTCR) include a net sale of 380,605 shares made by Preston Klassen , a net purchase of 271,605 shares made by Braden Michael Leonard , and a net sale of 107,054 shares made by Michael York .

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 487,659 shares of Metacrine Inc (MTCR) were sold and 271,605 shares were bought by its insiders, resulting in a net sale of 216,054 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Fund Viii, L.p. made no insider transaction in Denali Therapeutics Inc (DNLI). Other recent insider transactions involving Denali Therapeutics Inc (DNLI) include a net sale of 106,621 shares made by Alexander O. Schuth , a net sale of 42,800 shares made by Carole Ho , and a net sale of 186,802 shares made by Ryan J. Watts .

In summary, during the past 3 months, insiders sold 95,832 shares of Denali Therapeutics Inc (DNLI) in total and bought 0 shares, with a net sale of 95,832 shares. During the past 18 months, 460,892 shares of Denali Therapeutics Inc (DNLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 460,892 shares.

Denali Therapeutics Inc (DNLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Fund Viii, L.p. made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 21,335 shares made by Paul Alloway , a net sale of 23,653 shares made by Arthur Tzianabos , and a net sale of 5,068 shares made by Albert Seymour .

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,328 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,328 shares.

Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sienna Biopharmaceuticals Inc (SNNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Arch Venture Fund Viii, L.p. made no insider transaction in Scholar Rock Holding Corp (SRRK). Other recent insider transactions involving Scholar Rock Holding Corp (SRRK) include a net sale of 83,758 shares made by Edward H Myles , a net purchase of 2,279,168 shares made by Invus Public Equities, L.p. , and a net sale of 31,121 shares made by Mo Qatanani .

In summary, during the past 3 months, insiders sold 0 shares of Scholar Rock Holding Corp (SRRK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 128,112 shares of Scholar Rock Holding Corp (SRRK) were sold and 6,659,824 shares were bought by its insiders, resulting in a net purchase of 6,531,712 shares.

Scholar Rock Holding Corp (SRRK)'s detailed insider trading history can be found in Insider Trading Tracker table.